Liver Cancer Combined With Other Liver Diseases Driving Higher Death Rate And Health Care Costs For Us Seniors
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver...
Normothermic Machine Perfusion Can Salvage Fatty Livers For Transplantation
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver...
Improved Center-specific Practices May Ease Effects Of Socioeconomic Deprivation For Pediatric Liver Transplant Recipients
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the...
Long‐term quality of life of living liver donors: A Japanese nationwide survey
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Kayo Nojiri, Kaori Muto, Junichi Shimizu, Etsuko Soeda, Naoki Kawagishi, Shigeru Marubashi, Koichi Mizuta, Toshimi Kaido, Akinobu Taketomi, Hideki Ohdan, Shinji Uemoto, Norihiro Kokudo – 1 June 2022
Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD
Tolga Gidener, Ross A. Dierkhising, Kristin C. Mara, Terry M. Therneau, Sudhakar K. Venkatesh, Richard L. Ehman, Meng Yin, Alina M. Allen – 31 May 2022
GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond
Margit Mahlapuu, Mara Caputo, Ying Xia, Emmelie Cansby – 30 May 2022 – Nonalcoholic fatty liver disease (NAFLD) is defined by excessive accumulation of lipid droplets within hepatocytes. The STE20‐type kinases comprising the germinal center kinase III (GCKIII) subfamily – MST3, MST4, and STK25 – decorate intrahepatocellular lipid droplets and have recently emerged as critical regulators of the initiation and progression of NAFLD.
Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
Tsuyoshi Fukumoto, Tatsuya Minami, Makoto Moriyama, Tomoharu Yamada, Taijiro Wake, Mizuki Nishibatake Kinoshita, Naoto Fujiwara, Ryo Nakagomi, Takuma Nakatsuka, Masaya Sato, Kenichiro Enooku, Hayato Nakagawa, Mitsuhiro Fujishiro, Shuichiro Shiina, Kazuhiko Koike, Ryosuke Tateishi – 30 May 2022 – The prognostic impact of direct‐acting antivirals (DAAs) on patients with hepatitis C‐related hepatocellular carcinoma (C‐HCC) is still unclear. This study aimed to evaluate the prognosis of C‐HCC in the DAA era.
Autoimmune liver disease in gastrointestinal conditions
Raouf Nassar, Orith Waisbourd‐Zinman – 29 May 2022
Autoimmune liver disease in gastrointestinal conditions
Raouf Nassar, Orith Waisbourd‐Zinman – 29 May 2022
Financial burden in adults with chronic liver disease: A scoping review
Nneka N. Ufere, Nishant Satapathy, Lisa Philpotts, Jennifer C. Lai, Marina Serper – 28 May 2022 – The economic burden of chronic liver disease is rising; however, the financial impact of chronic liver disease on patients and families has been underexplored.